Our previous work has shown that in thyroid cancer patients with high miR-490-3p expression, PCBP1 mRNA is translationally inhibited, whereas in patients with low or basal miR-490-3p expression, PCBP1 protein is targeted for degradation [10,11]. This evidence concerns the gene PCBP1 and thyroid gland carcinoma.